SYNLOGIC, INC. Gain (Loss) on Disposition of Assets
SYNLOGIC, INC. (SYBX) reported Gain (Loss) on Disposition of Assets of $80.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-12
- SYNLOGIC, INC. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- SYNLOGIC, INC. gain (loss) on disposition of assets for the quarter ending 2025-06-30 was $200.00K, a 84.62% decline year-over-year.
- SYNLOGIC, INC. gain (loss) on disposition of assets for the quarter ending 2025-03-31 was $10.00K.
- SYNLOGIC, INC. gain (loss) on disposition of assets for fiscal 2025 was $80.00K, a 93.33% decline from fiscal 2024.
- SYNLOGIC, INC. gain (loss) on disposition of assets for fiscal 2024 was $1.20M.
- SYNLOGIC, INC. gain (loss) on disposition of assets for fiscal 2016 was -$128.00K.
- SYNLOGIC, INC. gain (loss) on disposition of assets for fiscal 2015 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $200.00K derived: sum of 3 quarters · filed 2026-03-12 | $80.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $200.00K derived: sum of 2 quarters · filed 2026-03-12 | $80.00K 10-Q · filed 2025-11-13 | $310.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-06-30 | $200.00K 10-K · filed 2026-03-12 | $80.00K 10-Q · filed 2025-08-07 | $310.00K derived: sum of 3 quarters · filed 2026-03-12 | $310.00K derived: sum of 4 quarters · filed 2026-03-12 |
| 2025-03-31 | $10.00K 10-Q · filed 2025-05-08 | $110.00K derived: sum of 2 quarters · filed 2026-03-12 | $110.00K derived: sum of 3 quarters · filed 2026-03-12 | $1.41M derived: sum of 4 quarters · filed 2026-03-12 |
| 2024-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $100.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.40M derived: sum of 3 quarters · filed 2026-03-12 | $1.20M 10-K · filed 2026-03-12 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.30M derived: sum of 2 quarters · filed 2026-03-12 | $1.10M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.30M 10-K · filed 2026-03-12 | $1.10M 10-Q · filed 2024-08-08 | ||
| 2017-09-30 | -$5.00K 10-Q · filed 2017-11-13 | |||
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | $128.00K derived: sum of 2 quarters · filed 2017-03-15 | -$128.00K 10-K · filed 2017-03-15 | |
| 2016-09-30 | $128.00K 10-K · filed 2017-03-15 | -$4.00K 10-Q · filed 2017-11-13 | ||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |